Sophie Belin - Publications

Affiliations: 
Biochemistry State University of New York, Buffalo, Buffalo, NY, United States 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Alam MM, Zhao XF, Liao Y, Mathur R, McCallum SE, Mazurkiewicz JE, Adamo MA, Feustel P, Belin S, Poitelon Y, Zhu XC, Huang Y. Deficiency of microglial autophagy increases the density of oligodendrocytes and susceptibility to severe forms of seizures. Eneuro. PMID 33472865 DOI: 10.1523/ENEURO.0183-20.2021  0.76
2021 Feltri ML, Weaver MR, Belin S, Poitelon Y. The Hippo pathway: horizons for innovative treatments of peripheral nerve diseases. Journal of the Peripheral Nervous System : Jpns. PMID 33449435 DOI: 10.1111/jns.12431  0.76
2020 Jeanette H, Marziali LN, Bhatia U, Hellman A, Herron J, Kopec AM, Feltri ML, Poitelon Y, Belin S. YAP and TAZ regulate Schwann cell proliferation and differentiation during peripheral nerve regeneration. Glia. PMID 33336855 DOI: 10.1002/glia.23949  0.76
2020 Robison LS, Gannon OJ, Thomas MA, Salinero AE, Abi-Ghanem C, Poitelon Y, Belin S, Zuloaga KL. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease. Journal of Neuroinflammation. 17: 285. PMID 32993686 DOI: 10.1186/s12974-020-01956-5  0.76
2020 Poitelon Y, Kopec AM, Belin S. Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism. Cells. 9. PMID 32230947 DOI: 10.3390/cells9040812  0.76
2019 Belin S, Herron J, VerPlank JJS, Park Y, Feltri LM, Poitelon Y. Corrigendum: YAP and TAZ Regulate and β in Schwann Cells. Frontiers in Molecular Neuroscience. 12: 256. PMID 31680860 DOI: 10.3389/fnmol.2019.00256  0.76
2019 Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Schwab MH, Nave K, et al. Corrigendum: Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy. Human Molecular Genetics. 28: 2282. PMID 31220267 DOI: 10.1093/hmg/ddz037  0.76
2019 Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Schwab MH, Nave K, et al. Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy. Human Molecular Genetics. PMID 30668730 DOI: 10.1093/hmg/ddz021  0.76
2018 Belin S, Ornaghi F, Shackleford G, Wang J, Scapin C, Lopez-Anido C, Silvestri N, Robertson N, Williamson C, Ishii A, Taveggia C, Svaren J, Bansal R, Markus Schwab H, Nave K, et al. Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy. Human Molecular Genetics. PMID 30535360 DOI: 10.1093/hmg/ddy420  0.76
2018 Scapin C, Ferri C, Pettinato E, Zambroni D, Bianchi F, Del Carro U, Belin S, Caruso D, Mitro N, Pellegatta M, Taveggia C, Schwab MH, Nave KA, Laura Feltri M, Wrabetz L, et al. Enhanced axonal Neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot-Marie-Tooth type 1B mouse model. Human Molecular Genetics. PMID 30481294 DOI: 10.1093/hmg/ddy411  0.52
2018 Fratta P, Ornaghi F, Dati G, Zambroni D, Saveri P, Belin S, D'Adamo P, Shy M, Quattrini A, Laura Feltri M, Wrabetz L. A nonsense mutation in Myelin Protein Zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function. Human Molecular Genetics. PMID 30239779 DOI: 10.1093/hmg/ddy336  0.52
2017 Belin S, Zuloaga KL, Poitelon Y. Influence of Mechanical Stimuli on Schwann Cell Biology. Frontiers in Cellular Neuroscience. 11: 347. PMID 29209171 DOI: 10.3389/fncel.2017.00347  0.76
2017 Cummings KA, Belin S, Popescu GK. Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-d-aspartate receptors. Neuropharmacology. PMID 28365212 DOI: 10.1016/j.neuropharm.2017.03.031  0.88
2017 Maneshi MM, Maki B, Gnanasambandam R, Belin S, Popescu GK, Sachs F, Hua SZ. Mechanical stress activates NMDA receptors in the absence of agonists. Scientific Reports. 7: 39610. PMID 28045032 DOI: 10.1038/srep39610  0.88
2016 Zhu H, Ornaghi F, Belin S, Givogri MI, Wrabetz L, Bongarzone ER. Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency. Journal of Neuroscience Research. PMID 27426866 DOI: 10.1002/jnr.23839  0.52
2013 Noseda R, Belin S, Piguet F, Vaccari I, Scarlino S, Brambilla P, Martinelli Boneschi F, Feltri ML, Wrabetz L, Quattrini A, Feinstein E, Huganir RL, Bolino A. DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 15295-305. PMID 24048858 DOI: 10.1523/JNEUROSCI.2408-13.2013  1
2010 Belin S, Kaya F, Burtey S, Fontes M. Ascorbic Acid and gene expression: another example of regulation of gene expression by small molecules? Current Genomics. 11: 52-7. PMID 20808524 DOI: 10.2174/138920210790217936  1
2009 Belin S, Kaya F, Duisit G, Giacometti S, Ciccolini J, Fontés M. Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression. Plos One. 4: e4409. PMID 19197388 DOI: 10.1371/journal.pone.0004409  1
2008 Kaya F, Belin S, Diamantidis G, Fontes M. Ascorbic acid is a regulator of the intracellular cAMP concentration: Old molecule, new functions? Febs Letters. 582: 3614-3618. PMID 18835269 DOI: 10.1016/j.febslet.2008.09.040  1
2008 Kaya F, Belin S, Micallef J, Blin O, Fontés M. Analysis of the benefits of vitamin cocktails in treating Charcot-Marie-Tooth disease type 1A. Muscle & Nerve. 38: 1052-4. PMID 18663735 DOI: 10.1002/mus.21071  1
2007 Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontés M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscular Disorders : Nmd. 17: 248-53. PMID 17303424 DOI: 10.1016/j.nmd.2006.12.008  1
Show low-probability matches.